BackBeat Medical
- Company typePrivate
- Founded2010
- HeadquartersNew Hope, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
BackBeat Medical firmographics
Firmographics- Name
- BackBeat Medical
- Legal name
- BackBeat Medical Inc.
- Website
- https://backbeatmedical.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Acquired
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
BackBeat Medical industry classification
Industry- Product category
- Cardiovascular Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation) (HLAHAFAL)
- akta.pro secondary industry
- Cardiac Rhythm Management (Pacemakers, ICDs, CRT) (HLAHAFAC)
Keywords
Where BackBeat Medical is headquartered
LocationHeadquarters
- HQ city
- New Hope
- HQ country
- United States
- HQ region
- North America
Markets served
BackBeat Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations
BackBeat Medical product offering
Product offeringCore offering
BackBeat Medical develops BackBeat® Cardiac Neuromodulation Therapy (CNT), a therapeutic medical device that uses novel pacing algorithms to treat hypertension through cardiac neuromodulation. The therapy offers a non-pharmacological interventional approach to blood pressure management by modulating cardiac activity with proprietary pacing patterns.
Differentiator
Problem solved
Functional benefit
Products and services
- BackBeat® Cardiac Neuromodulation Therapy (CNT)
Companies that use BackBeat Medical
Customer profileSegments1 record
Ideal customer profiles1 record
BackBeat Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
BackBeat Medical partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Orchestra BioMed, Inc.BackBeat Medical is now a wholly-owned subsidiary of Orchestra BioMed, Inc., a therapeutic device company focused on the development and commercialization of high impact, data-driven, transformational solutions for targeted high value unmet medical needs. The BackBeat Cardiac Neuromodulation Therapy (CNT) is one of Orchestra BioMed's leading products.
BackBeat Medical competitors and assessment
Company assessmentDirect peers
- CVRx: Developer of the Barostim baroreflex activation therapy system, an implanted neuromodulation device for heart failure and resistant hypertension. Closely comparable mechanism (electrical neuromodulation) and target indication.
- ReCor Medical: Developer of the Paradise ultrasound renal denervation system for hypertension. Most directly comparable as a device-based neuromodulation company pursuing durable blood-pressure reduction through an interventional approach.
Broad incumbents
- Medtronic: Markets the Symplicity renal denervation system for hypertension, the most clinically advanced non-pharmacological alternative to CNT. Comparable as a large incumbent with overlapping device-based hypertension strategy and deep cardiac rhythm management infrastructure.
- Boston Scientific: Major cardiac rhythm management and interventional cardiology incumbent with established pacing platforms. Comparable both as a potential CNT delivery platform partner and as a competitor in adjacent neuromodulation and CRM categories.
- Abbott: Operates one of the largest cardiac rhythm management businesses globally. Comparable as a pacing-platform incumbent whose device architecture and algorithm roadmap could either compete with or enable CNT-like pacing therapies.
- Orchestra BioMed: Parent company of BackBeat Medical and developer of multiple therapeutic device programs including CNT. Directly comparable as the strategic vehicle commercializing BackBeat's technology and operating in adjacent cardiovascular device categories.
Regional players
- Biotronik: Cardiac rhythm management device manufacturer with significant European presence. Comparable as a pacemaker/ICD manufacturer whose pacing platform and algorithm capabilities are adjacent to CNT's pacing-based neuromodulation therapy.
Emerging players
- Kona Medical: Developer of externally delivered focused ultrasound for renal denervation in hypertension. Comparable as a non-implant neuromodulation approach to drug-resistant hypertension, addressing the same unmet need as CNT.
- Ablative Solutions: Develops a chemical (alcohol-mediated) renal denervation therapy for hypertension. Comparable as an early-stage device-based hypertension therapy pursuing durable BP reduction via a catheter-delivered neuromodulation approach.
- Rox Medical: Developer of the ROX Coupler, an interventional device creating an arteriovenous fistula for treatment-resistant hypertension. Comparable as a device-based alternative therapy for the same patient population CNT targets.
Market position
Customer concentration
BackBeat Medical social profiles
Digital presenceBackBeat Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
BackBeat Medical leadership team
Management profileNumber of profiles
Profiles2 records
BackBeat Medical funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BackBeat Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BackBeat Medical
What does BackBeat Medical do?
BackBeat Medical develops BackBeat® Cardiac Neuromodulation Therapy (CNT), a therapeutic medical device that uses novel pacing algorithms to treat hypertension through cardiac neuromodulation. The therapy offers a non-pharmacological interventional approach to blood pressure management by modulating cardiac activity with proprietary pacing patterns.
Is BackBeat Medical a public or private company?
BackBeat Medical is a private company. It is classified as corporate owned and is currently acquired.
When was BackBeat Medical founded?
BackBeat Medical was founded in 2010. It employs 1 to 10 people.
Where is BackBeat Medical based?
BackBeat Medical is headquartered in New Hope, United States, in the North America region.
Who are BackBeat Medical's main competitors?
Direct peers on record are CVRx and ReCor Medical. Broad incumbents are Medtronic, Boston Scientific, Abbott and Orchestra BioMed. Biotronik is listed as a regional player. Emerging players are Kona Medical, Ablative Solutions and Rox Medical.
Does BackBeat Medical have an API?
No public API is recorded for BackBeat Medical.
What industry is BackBeat Medical in?
BackBeat Medical's product category is Cardiovascular Medical Devices. Its primary akta.pro industry code is HLAHAFAL, Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation), with a secondary code of HLAHAFAC, Cardiac Rhythm Management (Pacemakers, ICDs, CRT). Its NAICS code is 334510 and its SIC code is 3845.